News

The FDA has approved safety labeling revisions for fluticasone propionate and salmeterol xinafoate inhalation powder, pimozide tablets, and ceftriaxone sodium injection.
Puns aside, assessing for ED shouldn’t be hard. Dr Rachel Rubin shares a tool that makes men more comfortable talking about erectile dysfunction.
Alas, nutritional epidemiology studies! Dr F. Perry Wilson shares his level of trust in new data about olive oil consumption and dementia-related death.
An advisory body in Switzerland has proposed that the country end systematic breast cancer screening with mammography.
Tranexamic acid prophylaxis did not reduce bleeding among patients with hematologic malignancies and severe thrombocytopenia and may do more harm than good.
A randomized, controlled trial of Gilead's antiviral drug remdesivir is currently underway in China as a possible treatment for the virus.
Conclusions The present work highlights the remarkable convergence of schizophrenia negative symptomatology and autistic features. It shows that the PAUSS correlates substantially with the ADOS.
Health journalist Max Lugavere and Dr Richard Isaacson discuss the latest evidence around lifestyle approaches to Alzheimer's prevention.
Dr Neil Skolnik discusses the rationale for the new lower blood pressure target for adults with hypertension.
Despite contraindications, continued combined use of erectile dysfunction drugs and nitrates in men with stable heart disease is tied to a higher risk for death and CV events.
The Health InterNetwork: Access to Research Initiative (HINARI) provides free or low-cost access to more than 2,000 scientific publications for more than 1,000 health and research institutions in ...
A conceptual model of interactions between families, clinicians, and ICU determinants influencing goal-directed care for infants and children with chronic critical illness. *Adapted from Kelley et al ...